AU Patent

AU2016265932B2 — Antifungal compounds

Assigned to Mycovia Pharmaceuticals Inc · Expires 2020-10-08 · 6y expired

What this patent protects

The present invention relates to compounds of Formula (I): wherein R

USPTO Abstract

The present invention relates to compounds of Formula (I): wherein R

Drugs covered by this patent

Vivjoa (OTESECONAZOLE) · Mycovia Pharms

Patent Metadata

Patent number: AU2016265932B2
Jurisdiction: AU
Classification: —
Expires: 2020-10-08
Drug substance claim: No
Drug product claim: No
Assignee: Mycovia Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.